首页> 美国卫生研究院文献>other >Bone Density Screening and Re-screening in Postmenopausal Women and Older Men
【2h】

Bone Density Screening and Re-screening in Postmenopausal Women and Older Men

机译:绝经后女性和老年男性的骨密度筛查和再筛查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Clinical practice guidelines universally recommend bone mineral density (BMD) screening to identify osteoporosis in women aged 65 years and older. Risk assessment is recommended to guide BMD screening in postmenopausal women under age 65. Insufficient data are available to inform standard ages to start and stop BMD screening in postmenopausal women. Based on longitudinal studies of incident osteoporosis and fracture in postmenopausal women, an initial BMD test should be ordered for all women aged 65, and the frequency of re-screening should be based on age and BMD T score (more frequent testing for older age and lower T score). Although clinical practice guidelines recommend BMD screening according to risk factors for fracture in postmenopausal women under age 65, no standard approach to risk assessment exists. Minimal evidence is available to guide osteoporosis screening in men, but some experts recommend initiation of BMD screening in men at age 70.
机译:临床实践指南普遍建议进行骨矿物质密度(BMD)筛查,以识别65岁及以上女性的骨质疏松症。建议进行风险评估以指导65岁以下绝经后妇女的BMD筛查。没有足够的数据来告知标准年龄以开始和停止绝经后妇女的BMD筛查。根据对绝经后妇女发生骨质疏松症和骨折的纵向研究,应该对所有65岁的女性进行初次BMD测试,并且重新筛查的频率应基于年龄和BMD T评分(对年龄较大和较低的T分数)。尽管临床实践指南建议根据65岁以下绝经后女性骨折的危险因素进行BMD筛查,但尚无标准的风险评估方法。仅有极少的证据指导男性骨质疏松症筛查,但一些专家建议对70岁以下的男性进行BMD筛查。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号